Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 38Neoplasm Metastasis 14Liver Neoplasms 11Colorectal Neoplasms 11Cholangiocarcinoma 9Pancreatic Neoplasms 8Lung Neoplasms 8Colonic Neoplasms 7Breast Neoplasms 7Thyroid Nodule 6Recurrence 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 6Thyroid Neoplasms 5Rectal Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Prostatic Neoplasms 3Pain 3Kidney Neoplasms 3Barrett Esophagus 3Agnosia 3Thyroid Diseases 2Thyroid Cancer, Papillary 2Leiomyoma 2Hyperaldosteronism 2Gallbladder Neoplasms 2Cancer Pain 2Bile Duct Neoplasms 2Adrenocortical Adenoma 2

Interventions

nimotuzumab 2Gemcitabine 2surufatinib 1S 1 (combination) 1Radiofrequency Ablation 1Oxaliplatin 1Mass Screening 1Leucovorin 1Irinotecan 1Hematologic Tests 1Fluorouracil 1Blood Specimen Collection 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic cancer, adult × Radiofrequency Ablation × Clear all
NCT03152487 2019-02-11

Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis

AdventHealth

Phase NA Completed
28 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡